欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
SE/H/0568/005
药品名称
Matrifen
活性成分
Fentanyl 12.0 µg
剂型
Transdermal patch
上市许可持有人
Takeda Pharma AB Sweden
参考成员国 - 产品名称
Sweden (SE)
Matrifen
互认成员国 - 产品名称
Denmark (DK)
Belgium (BE)
Luxembourg (LU)
United Kingdom (Northern Ireland) (XI)
Ireland (IE)
Spain (ES)
Italy (IT)
Greece (GR)
Finland (FI)
Poland (PL)
Matrifen
Latvia (LV)
Lithuania (LT)
matrifen 100 mikrogramų/val. transderminiai pleistrai
Estonia (EE)
MATRIFEN
Hungary (HU)
Matrifen 100 mikrogramm/h transzdermális tapasz
Czechia (CZ)
Matrifen 100 mcg/h
许可日期
2006/08/04
最近更新日期
2024/10/02
药物ATC编码
N02AB03 fentanyl
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Additional Strength/Form
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final PL
|
SE_H_0568_005_Final PL
Date of last change:2024/09/06
Final SPC
|
SE_H_0568_005_Final SPC
Date of last change:2024/09/06
PubAR
|
SE_H_0568_005_PAR
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase